|
|
Enzyme-Linked Immunosorbent Assay (Latest Articles)
Latest indexed articles for 'Enzyme-Linked Immunosorbent Assay'
Articles 1 to 10 of 200:
16 Dec 2009
This longitudinal study assessed the influence of post-transplant clinical and therapeutic variables in 50 kidney transplant recipients aged 2-19 yr receiving a triple immunosuppressive regimen consisting of cyclosporine microemulsion (CsA), ...
rec_pub_19191807-longitudinal-evaluation-mycophenolic-acid-pharmacokinetics-pediatric.htm
29 Nov 2009
For patients with brain tumors identification of diagnostic and prognostic markers in easy accessible biological material, such as plasma or cerebrospinal fluid (CSF), would greatly facilitate patient management. MIC-1/GDF15 (growth differentiation ...
rec_pub_19521960-elevated-levels-mic-1-gdf15-cerebrospinal-fluid-patients-associated.htm
13 Nov 2009
Gastric cancer (GC) is 1 of the most common human cancers. Early detection remains the most promising approach to improving long-term survival of patients with GC. We previously performed Serial Analysis of Gene Expression (SAGE) on 4 primary GCs ...
rec_pub_19670418-serum-olfactomedin-4-gw112-hgc-1-combination-reg-iv-highly-sensitive.htm
13 Nov 2009
Matrix metalloproteinases (MMPs) are critically involved in tumor invasion and metastasis. However, failure of broad spectrum MMP inhibitors in clinical trials emphasizes the need for detailed analyses of the specific role of different MMPs in tumor ...
rec_pub_19610062-distinct-progression-associated-expression-tumor-stromal-mmps-hacat.htm
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
13 Nov 2009
Chemokines and chemokine receptors have been shown to be involved in metastatic process of prostate cancer (PCa). In this study, we show primary PCa tissues and cell lines (LNCaP and PC3) express CXCR5, a specific chemokine receptor for CXCL13. ...
rec_pub_19610059-clinical-biological-significance-cxcr5-expressed-prostate-cancer.htm
Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.
Nov 2009
BACKGROUND: Interferon beta (IFNbeta) effectively reduces disease activity in patients with multiple sclerosis (MS). Neutralizing antibodies (NAbs) can diminish or abolish the clinical efficacy of IFNbeta therapies. Biomarkers of the IFNbeta ...
rec_pub_19884577-effect-neutralizing-antibodies-biomarker-responses-interferon-beta.htm
30 Oct 2009
The study was to determine clinical utility of serum soluble interleukin (IL)-2 receptor (sIL-2Ralpha), beta(2)-microglobulin (beta(2)-M), lactate dehydrogenase (LDH) and erythrocyte sedimentation rate (ESR) as markers of diagnosis, prognosis and ...
rec_pub_19874554-serum-soluble-interleukin-2-receptor-beta2-microglobulin-lactate.htm
30 Oct 2009
Heat shock protein 16.3 (Hsp16.3) of Mycobacterium tuberculosis (MTB) containing T-cell and B-cell epitopes not only plays an important role in the survival of MTB against macrophages, but also has great potential to be used to develop new TB ...
rec_pub_19874551-new-alternative-vaccine-component-mycobacterium-tuberculosis-heat.htm
30 Oct 2009
Novel immunogenic antigens are continually required for the improvement of diagnostic techniques for Mycobacterium tuberculosis infection. Some proteins with serodiagnostic value are not expressed under normal culture conditions, but may be induced ...
rec_pub_19874550-identification-rv2041c-novel-immunogenic-antigen-mycobacterium.htm
30 Oct 2009
Transplantation of neural stem cells (NSCs) has shown promise for improving functional recovery after spinal cord injury (SCI). The inhospitable milieu of injured spinal cord, however, does not support survival of grafted NSCs, reducing therapeutic ...
rec_pub_19530162-overexpression-bcl-xl-human-neural-stem-cells-promotes-graft-survival.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]